|
ONCY Oncolytics Biotech Inc 1129928 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-9,442,000.00 |
| Balance Sheet |
|
Current Assets
|
$7,069,000.00 |
|
Assets
|
$20,187,000.00 |
|
Current Liabilities
|
$5,225,000.00 |
|
Liabilities
|
$14,204,000.00 |
|
Equity
|
$-6,167,000.00 |
|
Shares Out
|
124637521.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-15,431,000.00 |
|
Investing Cash Flow
|
$-6,000.00 |
| Market Analysis |
Market Cap
|
$99,710,016.80 |
|
Price
|
$0.80 |
|
PB
|
17.67 |
|
EPS
|
-0.08 |
|
FCF
|
$-15,437,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:50 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:41 |
|
| Apr |
May |
Jun |
| 2026-03-30 |
-0.22 |
|
|
2026-05-14 |
-0.06 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-08 |
-0.05 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.10 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ONCY documents filed with the SEC.
ONCY Filings
Clear
